MyRocky GLP-1 Review (2026): Authorised Generic Semaglutide at $149
One molecule, one route, priced properly. MyRocky is semaglutide-only, and that narrowness is exactly why it costs what it does — here is what the trade buys and what it forecloses.
Reviewed · GLP1Injections Canada editorial team
About MyRocky
MyRocky is a Canadian telehealth provider that pairs an online clinic with an in-house licensed pharmacy. It is LegitScript certified, has enrolled over 350,000 Canadians, and names its clinical leadership publicly — Dr. George Mankaryous, MD CCFP, and pharmacist-in-charge Mina Rizk, RPh MPharm. Naming the responsible clinicians is not universal in this market, and it matters.
The core offer is generic semaglutide — the same active molecule as Ozempic — from around $149 per month, which undercuts brand-name programs substantially. Canada became the first G7 country to authorize a generic semaglutide, and MyRocky was among the first Canadian platforms to build a program around it.
The in-house pharmacy matters more for an incretin than for most prescriptions. GLP-1 therapy is a titration schedule, not a single fill: you step up through doses over weeks, and a refill that arrives late does not merely inconvenience you, it interrupts the escalation your prescriber planned. MyRocky dispenses in-house, so there is no prescription transfer between two organisations to stall at exactly the point a dose changes.
MyRocky also serves all ten provinces, including Quebec and New Brunswick. Quebec is regulated separately through the Collège des médecins du Québec and is excluded by most national platforms, so for Quebec residents this is frequently the only real option.
At a Glance
| Generic semaglutide | From ~$149/month |
|---|---|
| Initial consultation | $99 one-time |
| Brand-name options | Ozempic and Mounjaro available, dose-dependent |
| Pharmacy | In-house licensed pharmacy — no third-party transfer |
| Provinces served | All 10, including Quebec and New Brunswick |
| Follow-up | 4-week titration cadence, included |
| Guarantee | 6-month money-back guarantee (terms apply) |
| Certification | LegitScript certified |
Pros and Cons
Pros
- ✓Generic semaglutide from around $149/month — among the lowest all-in pricing in Canada
- ✓The only major Canadian platform serving all ten provinces, including Quebec
- ✓In-house licensed pharmacy means faster fulfilment with no third-party transfer delay
- ✓Structured 4-week follow-up for dose titration, included in the consultation fee
- ✓LegitScript certified with named, credentialed clinical and pharmacy leadership
- ✓6-month money-back guarantee for patients who complete the program without meaningful loss
Cons
- ✗Semaglutide only — no tirzepatide, so it cannot serve a reader prescribed a dual agonist
- ✗The $99 consultation is charged whether or not you are approved
- ✗Does not directly bill private insurance — you submit itemized receipts yourself
- ✗No brand-name option for readers who want the originator product specifically
How It Works
- 1.Complete the online health intake
Seven to ten minutes covering your weight history, conditions and current medications.
- 2.A licensed Canadian physician reviews it
Typically within 24 hours, with lab ordering through the partner lab network if needed.
- 3.Pay the $99 consultation
This covers the full clinical assessment, lab review, and first prescription if you are eligible. It is charged whether or not you are approved.
- 4.In-house pharmacy dispenses
Free tracked courier delivery in discreet packaging, dispatched directly rather than routed to a third-party pharmacy.
- 5.Titrate on a 4-week cadence
Structured follow-up for dose adjustment plus provider messaging, at no extra charge.
Pricing
| Consultation | $99 one-time |
|---|---|
| Generic semaglutide | From ~$149/month |
| Brand-name Ozempic | ~$200–$420/month depending on dose |
| Mounjaro (tirzepatide) | ~$350–$630/month depending on dose |
| Membership fee | None — ongoing support included in the $99 consult |
| Delivery | Free tracked courier, discreet packaging |
Generic semaglutide pricing holds far closer to flat across a titration than brand-name pricing does, which is why the gap between routes widens as you climb. Price the maintenance dose, not the starting dose.
Who It's For
A good fit if…
- • Semaglutide is the molecule you are on or heading for
- • You want the flattest cost curve across a titration
- • You live in Quebec, which most platforms in this class do not serve
- • You want dispensing and prescribing under one roof for refill reliability
Look elsewhere if…
- • You are unsure you will qualify and do not want to risk a $99 non-refundable consult
- • You specifically want brand-name Wegovy→ Felix carries the brand-name product.
- • You need a provider that bills private insurance directly
How It Compares
Rankings on this site weigh all-in cost in CAD, provincial coverage, clinical model and pharmacy model. Compare MyRocky against the alternatives before you commit:
Frequently Asked Questions
Is generic semaglutide the same molecule as Ozempic?+
Can MyRocky prescribe tirzepatide?+
Why does in-house dispensing matter for a GLP-1?+
Does MyRocky serve Quebec?+
Which providers do you recommend in Canada?
Recommended Providers
Our editorial team’s top picks for this category.
Editorial Verdict
Within the GLP-1 class, MyRocky is the cleanest semaglutide route in Canada. Same active molecule as Ozempic, authorized on demonstrated bioequivalence, at roughly $149 a month — and, importantly for a class that titrates, on a much flatter cost curve than the brand-name alternatives.
The in-house pharmacy matters more here than it would for a one-off prescription. GLP-1 therapy is a dose-escalation schedule, and each step up is another dispense that has to arrive on time. Removing the transfer between two organisations removes the most common place that goes wrong.
The limit is the formulary. This is semaglutide and nothing else — no tirzepatide, no liraglutide. Within the class that is a narrow shelf, and if your prescriber has put you on a different molecule, no amount of price advantage makes this the right program.
Prescription notice
Provider independence
References and further reading
- Health Canada, Canada becomes the first G7 country to approve a generic semaglutide (Health Canada). First Canadian authorization of a generic semaglutide (2026).
- Health Canada, Canada approves first generic semaglutide for weight loss (Health Canada). First generic semaglutide authorized for chronic weight management.
- NEJM, STEP 1 trial of semaglutide for weight loss (New England Journal of Medicine). Landmark trial evidence for weight-loss effectiveness.
- Obesity Canada and CMAJ, 2025 pharmacotherapy guideline (CMAJ / Obesity Canada). Canadian obesity guideline on long-term weight-management medicine.
Compare Other Providers
Related Guides
Explore More Treatments
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.